COVID-19 vaccines for children: An expert explains
The Pfizer/BioNTech vaccine is set to be approved for children aged 5-11 in the United States. Image: REUTERS/Dado Ruvic/File Photo/File Photo
Explore and monitor how COVID-19 is affecting economies, industries and global issues
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
COVID-19
India’s leading COVID-19 last-mile responders
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
Related topics:
The Agenda Weekly
A weekly update of the most important issues driving the global agenda
You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.
More on COVID-19See all
Felix Richter
February 2, 2023
Stephen Hall
February 1, 2023
Simon Torkington
January 30, 2023
Felix Richter
January 25, 2023
Pooja Chhabria
January 19, 2023
Seth Berkley
January 16, 2023